InFlectis BioScience is a startup based in France, most recent round Series B, 1 tracked investor.
InFlectis BioScience is a startup based in France. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
InFlectis BioScience is a clinical-stage biotechnology company developing first-in-class therapies for rare neurological diseases by inhibiting the integrated stress response.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.